Abstract. Effects of a free radical scavenger, edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), on ischemia / reperfusion-induced dysfunctions of rat striatal dopaminergic neurons were examined using in vivo brain microdialysis. During transient forebrain ischemia, dopamine levels in dialysates were elevated 140-fold above controls but rapidly recovered after reperfusion. The increase in dopamine levels induced by high K + stimulation after reperfusion was far smaller than that of the controls. Pretreatment with edaravone but not post-treatment dose-dependently improved the response to high K + but not the massive dopamine increase during ischemia. These results suggest that free radicals produced during ischemia play more important roles in ischemia/ reperfusion-induced dysfunctions of dopaminergic neurons.
Reactive oxygen species (ROS) such as superoxide anion radical (
• O 2 − ), hydrogen peroxide (H 2 O 2 ), hydroxyl radical (
• OH), and peroxynitrite anion (ONOO − ) are reported to play an important role in ischemic brain injury (1 -3) . ROS are produced during cerebral ischemia through various biological reactions, including the mitochondrial respiratory chain, xanthine-xanthine oxidase system, nitric oxide synthase, and lipid peroxidation (1, 4) . Activation of neutrophils is another source of ROS (5) . Generated ROS cause lipid peroxidation, protein oxidation, and DNA damage (6) . Notably, generation of ROS becomes prominent during reperfusion because reperfusion causes resupply of oxygen and substrates to energy-deprived and metabolically perturbed tissue (1) . Furthermore, experimental studies using rodent models of focal ischemia have shown that ROS production is also notable in the boundary zone of infarct (called ischemic penumbra) during both ischemia and reperfusion (2, 3) . So far, the effects of numerous free radical scavengers on ischemic tissue damage have been evaluated (1) . Of these, edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one) has been proven to be beneficial for patients with acute ischemic stroke in Japan (7) as well as in rodent models of transient ischemia (8, 9) . Extracellular levels of neurotransmitters monitored by in vivo brain microdialysis reflect the activity of neurons containing that neurotransmitter. Microdialysis experiments showed that extracellular levels of neurotransmitters including dopamine and glutamate (10, 11) are markedly elevated during transient ischemia, but they rapidly return to pre-ischemic level after reperfusion, indicating that dysfunctions of the neurons are only transient. However, we showed that high K + stimulationinduced dopamine release, as an index of reactivity of dopaminergic neurons to external stimuli, are markedly reduced for a long time after reperfusion (11) , indicating that dysfunction of dopaminergic neurons persists even after reperfusion. To get insights into the pathogenesis and treatment for functional disturbances of dopaminergic neurons during transient ischemia and subsequent reperfusion, we examined the effects of a free radical scavenger edaravone on the ischemia-induced elevation of extracellular dopamine levels and the suppression of high K + stimulation-induced increase in the levels. Animal experiments were carried out according to the Guidelines for Hokkaido University School of Medicine Animal Care and Use Committee. Male Wistar rats, weighing 250 -300 g, were subjected to transient forebrain ischemia by four-vessel occlusion (11, 12) .
That is, the rats were anesthetized with halothane (1.5% -2.0% during surgical preparation and 0.3% -0.5% during brain microdialysis) in O 2 / N 2 O (1:1) delivered through tracheostomy by a rodent Starling type ventilator (Harvard Apparatus, Edenbridge, UK). Mean arterial blood pressure, arterial blood gases, and pH were monitored from a femoral artery. The respiratory rate and volume were adjusted to obtain arterial O 2 and CO 2 tensions of 100 -120 and 30 -35 mmHg, respectively; and if necessary, sodium bicarbonate was given intravenously to correct for acidosis. Body temperature was kept at 37°C with a heating pad. Both common carotid arteries were isolated and separately encircled with a loose-fitting suture, both ends of the suture passing through a polyethylene tube to be brought out of the wound. The vertebral arteries on both sides were permanently electrocoagulated under the operating microscope. Thirty minutes after occlusion of vertebral arteries, a U-shaped microdialysis probe (BDP 21-03; EICOM, Kyoto) was implanted in the right striatum, fixed, and perfused at a flow rate of 6.3 µl / min with Ringer solution (147 mM NaCl, 4 mM CaCl 2 , and 2.3 mM KCl, pH 6.1), as described (11, 13) . Following 2-h perfusion, dialysates were collected every 10 min. After collection of four fractions, forebrain ischemia was produced for 30 min by tightening the carotid sutures bilaterally, and for reperfusion, the sutures were loosened. Control rats had the same surgical procedures but without carotid occlusion. Edaravone (donated by Mitsubishi Pharma Corporation, Tokyo) was intravenously given 10 min before production of ischemia, unless otherwise stated. In some experiments, edaravone was given immediately after reperfusion. The striatum was stimulated by high K + -containing dialyzing fluid (final concentration, 100 mM) for 20 min, starting from 1 h after reperfusion or at the corresponding time in control rats. The high K + solution was prepared by replacing NaCl with the equimolar concentration of KCl. Dopamine collected in dialysates was purified by a small-scale alumina batch method and determined using HPLC with electrochemical detection as reported (11, 13) . All data were expressed as the mean ± S.E.M. and analyzed using two-way analysis of variance (ANOVA) followed by Newman-Keuls' multiple-range test when appropriate. A probability level of P<0.05 was considered statistically significant. The in vitro recovery of dopamine through the microdialysis probe was 6.8%.
As shown in Fig. 1 , dopamine levels in dialysates were stable for at least 210 min in control rats, in which vertebral arteries but not common carotid arteries were occluded. When rats with occlusion of bilateral vertebral arteries were subjected to ischemia by pulling tight the sutures of the bilateral common carotid arteries, dopamine levels in the dialysates remarkably increased to about 140-fold of the control level. Upon reperfusion by loosening the sutures, dopamine levels in dialysates rapidly returned to the control level within 30 min. When the striatum of control rats was stimulated by high K + (100 mM)-containing dialyzing fluid, dopamine levels increased to 50-fold of the control level. The same stimulation, applied 1 h after reperfusion, induced a far smaller increase (35% of control) in dopamine levels than that in control rats ( Figs. 1 and 2) . Administration of edaravone (3 mg / kg, i.v.) 10 min before the beginning of ischemia was without effect on the massive increase of dopamine levels in dialysates during ischemia (Fig. 1) , but it improved the response to high K + stimulation after reperfusion from 35% of controls to 65% (Figs. 1 and 2) . In control rats, edaravone (3 mg / kg, i.v.) had no effect on basal and high K + -stimulated dopamine levels (Fig. 2) . The effects of edaravone on the response to high K + stimulation after reperfusion were dose-dependent and reached the maximum at doses ≥3 mg/ kg. In contrast, administration of edaravone (3 mg / kg, i.v.) immediately after reperfusion had no significant effect on the reduced response to high K + stimulation (Fig. 2) . The present study showed that although pretreatment with edaravone, a free radical scavenger, did not affect the massive dopamine release during ischemia, it improved reduction of high K + -induced dopamine release after reperfusion, indicating that free radicals are involved in the reduced response after reperfusion but not in massive dopamine release during ischemia. Two mechanisms for dopamine release have been suggested based on in vitro studies with brain slices. One is the rapid Ca 2+ -dependent exocytotic release from synaptic vesicles upon depolarization of the plasma membrane (14) , and the other is the slow Ca
2+
-independent carrier-mediated release that is carried out by dopamine transporter working in a reversed mode (15) . Because the exocytotic release requires ATP, the Ca 2+ -independent carrier-mediated release is primarily predominant during ischemia. On the other hand, high K + -induced dopamine release is mainly Ca 2+ -dependent exocytotic release, and hence, it reflects neuronal function and energy state. As massive dopamine release during ischemia is the result of energy depletion, edaravone as a radical scavenger seems to be ineffective for it.
In contrast, edaravone (given before ischemia) was effective for post-ischemic reduction of high K + -induced dopamine release. Edaravone is reported to have protective effects against ischemia / reperfusion-induced brain injury in several experimental models, and its effectiveness seems to be associated with the drug's ability to scavenge a variety of free radicals, especially hydroxyl radicals, produced during ischemia / reperfusion (8, 9) . Therefore, it is likely that the reduction of high K + -induced dopamine release after reperfusion is the result of ROS-induced damage to dopaminergic neurons. High K + -induced dopamine release consists of the following sequence of events: 1) depolarization of the neuronal membrane, 2) activation of voltage-dependent Ca 2+ channels, and 3) activation of exocytotic release. Considering that ROS can cause lipid peroxidation, protein oxidation, and DNA damage (see the Introduction), voltage-dependent Ca 2+ channels and the molecules involved in exocytotic release might have been modified by ROS, leading to reduction of depolarization-induced dopamine release. Notably, the reduction of high K + -induced dopamine release after reperfusion has not completely been recovered even after administration of the maximal dose of edaravone. This might reflect involvement of ROS-independent mechanism or of ROS that are not scavenged by edaravone. Finally, when given immediately after reperfusion, edaravone was ineffective against post-ischemic reduction of high K + -induced dopamine release. This result indicates that ROS generated during ischemia play a more important role in development of ischemia / reperfusion-induced brain injury to dopaminergic neurons.
In conclusion, the present study shows that free radicals play an important role in the genesis of postischemic neuronal dysfunction, which is partially improved by a free radical scavenger. -stimulated dopamine release in rat striatum after ischemia / reperfusion. After pretreatment with varying doses of edaravone (i.v. given 10 min before ischemia), rats were subjected to either 30-min ischemia (closed bar) or sham-operation (open bar), and subsequently their striatum was stimulated by high K + (100 mM in dialyzing fluid). In one group, edaravone was given immediately after reperfusion (hatched bar). Each column represents the mean ± S.E.M. of six determinations, each of which is the average of dopamine levels in two fractions of dialysates during high K + stimulation. **P<0.01, significantly different from each other.
